2021 Results and Financial Review

Footnotes (2) Slide Reference 1. 17 Footnote There are important notices relating the B Share Scheme and illustrative share consolidation ratio and illustrative future dividend per share on page 2 of this presentation. Please read these notices in full in order to obtain a comprehensive understanding of the Company's proposals. Illustrative dividends are subject to change. The Board has not approved or made any decision to pay any dividend in respect of any future period. The 2022 and 2023 DPS figures have been calculated to show the estimated dividend per share following the share consolidation using an illustrative consolidation ratio 2. From continuing operations 1. 18 2. 1. 19 2. Subject to shareholder approval and other customary conditions, including no material deterioration in market conditions or the Company's financial position. There are important notices relating the B Share Scheme and illustrative share consolidation ratio and illustrative future dividend per share on page 2 of this presentation. Please read these notices in full in order to obtain a comprehensive understanding of the Company's proposals Settlement of B Share Scheme for American Depositary Shareholders expected to take place in June 2022 Controllable costs excluding IFRS 17, cost implementation and planned investment in growth £2,856 million reported controllable costs adjusted by £2 million in respect of the impacts of foreign exchange movements and non-insurance operations relating to Europe and Asia which are excluded from our cost savings target (consistent with 2018 baseline) Based on a blended inflation assumption of CPI and Aviva wage inflation. 3. 20 1. Controllable costs excluding IFRS 17 & implementation costs 21 1. 22 1. Compound annual growth rate References to sales represent present value of new business premiums (PVNBP) 23 1. References to sales represent present value of new business premiums (PVNBP) 24 1. 27 1. 1. 28 2. Controllable costs excluding IFRS 17 & implementation costs Represents Aviva Investors revenue. Further guidance in respect of the APMs used by the Group can be found in the 'Other information' section of the 2021 Results Announcement 3.75bn B Share Scheme (subject to shareholder approval and other customary conditions, including no material deterioration in market conditions or the Company's financial position) in addition to existing £1bn share buyback There are important notices relating the B Share Scheme and illustrative share consolidation ratio and illustrative future dividend per share on page 2 of this presentation. Please read these notices in full in order to obtain a comprehensive understanding of the Company's proposals. Illustrative dividends are subject to change. The Board has not approved or made any decision to pay any dividend in respect of any future period. The 2022 and 2023 DPS figures have been calculated to show the estimated dividend per share following the share consolidation using an illustrative consolidation ratio Aviva's analysis using latest information available including company reporting, Fundscape, Hymans Robertson, LaingBuisson Healthcover, Swiss Re Group Watch, Corporate adviser, Fundscape and Insurance Ireland. Individual Wealth refers to Advised 31 1. Wealth 32 1. Aviva estimates. Sources used include Oliver Wyman, ONS, MSA, PPF Purple Book 2021, Hymans Robertson and LCP 33 1. 34 1. 1. 35 2. Compound annual growth rate Compound annual growth rate As at 31 December 2021. Includes assets under administration of £1.3 billion and 2,000 clients related to 4 announced transactions which are expected to complete during 2022. Proforma basis including full run-rate contribution from 4 announced transactions which are expected to complete during 2022 AVIVA 99 65

View entire presentation